Prostaglandins and cancer: a review of tumor initiation through tumor metastasis.
D000818:Animals; D001564:Benzo(a)pyrene; D001580:Benzopyrenes / Q000378:metabolism; D002273:Carcinogens / Q000494:pharmacology; D002454:Cell Differentiation; D002455:Cell Division; D002471:Cell Transformation, Neoplastic / Q000139:chemically induced; D016861:Cyclooxygenase Inhibitors; D004247:DNA / Q000378:metabolism; D011464:Epoprostenol / Q000502:physiology; D005260:Female; D006412:Hematopoietic Stem Cells / Q000166:cytology; D006801:Humans; D007668:Kidney / Q000187:drug effects; D008297:Male; D009153:Mutagens / Q000494:pharmacology; D009362:Neoplasm Metastasis / Q000503:physiopathology; D009369:Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology*; D010084:Oxidation-Reduction; D011453:Prostaglandins / Q000502:physiology* / Q000627:therapeutic use; D011457:Prostaglandins D / Q000502:physiology; D011458:Prostaglandins E / Q000502:physiology; D011460:Prostaglandins F / Q000502:physiology; D012867:Skin / Q000187:drug effects; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D013928:Thromboxane A2 / Q000502:physiology
D001580:Benzopyrenes; D002273:Carcinogens; D016861:Cyclooxygenase Inhibitors; D009153:Mutagens; D011453:Prostaglandins; D011457:Prostaglandins D; D011458:Prostaglandins E; D011460:Prostaglandins F; D001564:Benzo(a)pyrene; D013928:Thromboxane A2; D004247:DNA; D011464:Epoprostenol; D013755:Tetradecanoylphorbol Acetate